Equity Screeners to view more equity screening toolsThe Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also
Price to Sales AnalysisPrice to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Distress Driver Correlations
Return on Sales Over TimeReturn on Sales is a ratio to evaluate a company's operational efficiency, calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont return on equity.
About Price to SalesThe most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
|Compare to competition|
Based on latest financial disclosure the price to sales indicator of DarioHealth Corp is roughly 3.86 times. This is much higher than that of the sector, and significantly higher than that of Medical Equipment industry, The Price to Sales for all stocks is over 1000% lower than the firm.
DarioHealth Corp Fundamental Drivers Relationships
DarioHealth Corp is rated # 3 in number of employees category among related companies. It is rated # 2 in cash per share category among related companies fabricating about 0.02 of Cash per Share per Number of Employees. The ratio of Number of Employees to Cash per Share for DarioHealth Corp is roughly 44.19